- 著者
- Takao Fujisawa Terufumi Shimoda Keisuke Masuyama Kimihiro Okubo Kohei Honda Mitsuhiro Okano Toshio Katsunuma Atsuo Urisu Yasuto Kondo Hiroshi Odajima Kazuyuki Kurihara Makoto Nagata Masami Taniguchi Shoichiro Taniuchi Satoru Doi Tomoshige Matsumoto Shoji Hashimoto Akihiko Tanaka Kensuke Natsui Nahoko Abe Hideki Ozaki
- 出版者
- Japanese Society of Allergology
- 雑誌
- Allergology International (ISSN:13238930)
- 巻号頁・発行日
- vol.67, no.3, pp.347-356, 2018 (Released:2018-07-28)
- 参考文献数
- 49
- 被引用文献数
- 7
Background: To evaluate the long-term safety of subcutaneous immunotherapy with TO-204, a standardized house dust mite (HDM) allergen extracts, we conducted a multicenter, open label clinical trial.Methods: Japanese patients aged 5-65 years were eligible for the study, if they had HDM-induced allergic rhinitis (AR), allergic bronchial asthma (BA), or both. TO-204 was administered in a dose titration scheme, and the maintenance dose was determined according to the predefined criteria. The treatment period was 52 weeks, and patients who were willing to continue the treatment received TO-204 beyond 52 weeks. This clinical trial is registered at the Japan Pharmaceutical Information Center (Japic CTI-121900).Results: Between July 2012 and May 2015, 44 patients (28 with AR and 16 with allergic BA) were enrolled into the study. All patients were included in the analysis. The duration of treatment ranged from 23 to 142 weeks and the median maintenance dose was 200 Japanese allergy units (JAU). Adverse events occurred in 22 patients (50%). The most common adverse event was local reactions related to the injection sites. Four patients experienced anaphylactic reactions when they were treated with the dose of 500 JAU. Two patients experienced anaphylactic shock with the doses of 1000 JAU at onset. These 6 patients could continue the study with dose reduction.Conclusions: Safety profile of TO-204 was acceptable in Japanese patients with HDM-induced AR or allergic BA. Higher doses should be administered carefully, because the risk of anaphylaxis increased at doses of 500 or 1000 JAU.
- 著者
- Liqing SHA Munemasa TERAMOTO Nam Jin NOH Shoji HASHIMOTO Meng YANG Montri SANWANGSRI Naishen LIANG
- 出版者
- The Society of Agricultural Meteorology of Japan
- 雑誌
- 農業気象 (ISSN:00218588)
- 巻号頁・発行日
- vol.77, no.1, pp.24-51, 2021 (Released:2021-01-10)
- 参考文献数
- 383
- 被引用文献数
- 1 9
Soil respiration (Rs) is the largest flux of carbon dioxide (CO2) next to photosynthesis in terrestrial ecosystems. With the absorption of atmospheric methane (CH4), upland soils become a large CO2 source and CH4 sink. These soil carbon (C) fluxes are key factors in the mitigation and adaption of future climate change. The Asian region spans an extensive area from the northern boreal to tropical regions in Southeast Asia. As this region is characterised by highly diverse ecosystems, it is expected to experience the strong impact of ecosystem responses to global climate change. For the past two decades, researchers in the AsiaFlux community have meaningfully contributed to improve the current understanding of soil C dynamics, response of soil C fluxes to disturbances and climate change, and regional and global estimation based on model analysis. This review focuses on five important aspects: 1) the historical methodology for soil C flux measurement; 2) responses of soil C flux components to environmental factors; 3) soil C fluxes in typical ecosystems in Asia; 4) the influence of disturbance and climate change on soil C fluxes; and 5) model analysis and the estimation of soil C fluxes in research largely focused in Asia.